The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Treace John T. since 2021.
This trader's CIK number is 1856380.
At the time of last reporting, Treace John T. was the Chief Executive Officer of Treace Medical Concepts, Inc.. (stock ticker symbol TMCI).
Also see all insider trading activities at Treace Medical Concepts, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | TMCI | 630,000 | $3,178,839 | 0 | $0 | 0 | $0 |
| 2023 | TMCI | 0 | $0 | 2,075 | $50,650 | 0 | $0 |
| 2022 | TMCI | 105,000 | $2,159,671 | 0 | $0 | 0 | $0 |
| 2021 | TMCI | 0 | $0 | 5,748,805 | $98,709,138 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-16 | TMCI | Buy | 50,000 | 5.31 | 265,650 |
| 2024-08-14 | TMCI | Buy | 85,000 | 6.00 | 510,339 |
| 2024-06-11 | TMCI | Buy | 45,000 | 5.88 | 264,600 |
| 2024-05-14 | TMCI | Buy | 150,000 | 5.12 | 767,850 |
| 2024-05-10 | TMCI | Buy | 150,000 | 4.58 | 686,850 |
| 2024-05-13 | TMCI | Buy | 150,000 | 4.56 | 683,550 |
| 2023-03-09 | TMCI | Sale | 2,075 | 24.41 | 50,650 |
| 2022-11-21 | TMCI | Buy | 15,000 | 21.83 | 327,405 |
| 2022-11-17 | TMCI | Buy | 10,000 | 21.67 | 216,710 |
| 2022-11-17 | TMCI | Buy | 10,000 | 21.67 | 216,710 |
| 2022-11-17 | TMCI | Buy | 10,000 | 21.67 | 216,710 |
| 2022-09-01 | TMCI | Buy | 10,000 | 19.80 | 198,030 |
| 2022-08-26 | TMCI | Buy | 21,491 | 20.95 | 450,343 |
| 2022-08-23 | TMCI | Buy | 28,000 | 18.72 | 524,132 |
| 2022-08-24 | TMCI | Buy | 509 | 18.92 | 9,631 |
| 2021-12-28 | TMCI | Sale | 19,760 | 16.99 | 335,801 |
| 2021-12-29 | TMCI | Sale | 3,075 | 17.01 | 52,314 |
| 2021-12-22 | TMCI | Sale | 41,710 | 16.29 | 679,372 |
| 2021-12-23 | TMCI | Sale | 22,795 | 16.96 | 386,534 |
| 2021-12-27 | TMCI | Sale | 17,165 | 17.44 | 299,374 |
| 2021-12-20 | TMCI | Sale | 22,911 | 16.02 | 367,080 |
| 2021-12-21 | TMCI | Sale | 37,584 | 16.23 | 609,875 |
| 2021-11-24 | TMCI | Sale | 56,000 | 17.83 | 998,536 |
| 2021-11-23 | TMCI | Sale | 56,000 | 17.69 | 990,472 |
| 2021-11-22 | TMCI | Sale | 53,000 | 18.73 | 992,425 |
| 2021-10-20 | TMCI | Sale | 30,827 | 25.08 | 773,048 |
| 2021-10-21 | TMCI | Sale | 76,084 | 22.25 | 1,692,716 |
| 2021-10-22 | TMCI | Sale | 58,089 | 20.95 | 1,216,906 |
| 2021-04-27 | TMCI | Sale | 5,253,805 | 17.00 | 89,314,685 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Treace John T. (Chief Executive Officer of Treace Medical Concepts, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.